The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

被引：1
作者：
Avivi, Irit [1 ,2 ]
Gatt, Moshe E. [3 ,4 ]
Luttwak, Efrat [1 ]
Magen, Hila [2 ,5 ]
Dally, Najib [6 ,7 ]
Cohen, Yael C. [1 ,2 ]
Benyamini, Noam [1 ]
Lavi, Noa [8 ,9 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, Dept Hematol, Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel
[3] Hadassah Med Ctr, Dept Hematol, Jerusalem, Israel
[4] Hebrew Univ Jerusalem, Jerusalem, Israel
[5] Sheba Med Ctr, Dept Hematol, Tel Hashomer, Israel
[6] Ziv Med Ctr, Inst Hematol, Safed, Israel
[7] Bar Ilan Univ, Azrieli Fac Med, Safed, Israel
[8] Rambam Hlth Care Campus, Dept Hematol & Bone Marrow Transplantat, 8 HaAliya St, IL-31096 Haifa, Israel
[9] Technion, Ruth & Bruce Rappaport Fac Med, Technion, Israel
来源：
LEUKEMIA RESEARCH | 2020年 / 97卷
关键词：
Venetoclax relapsed refractory multiple myeloma t(11; 14); Levofloxacin prophylaxis; DEXAMETHASONE; EFFICACY;
D O I：
10.1016/j.leukres.2020.106429
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 12 条
[1]  
[Anonymous], 2019, BLOOD S1, DOI DOI 10.1182/BLOOD-2019-126094
[2]   Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma [J].
Basali, Diana ;
Chakraborty, Rajshekhar ;
Rybicki, Lisa ;
Rosko, Nathaniel ;
Reed, Janice ;
Karam, Maryann ;
Schlueter, Kristen ;
Dysert, Hayley ;
Kalaycio, Matt ;
Valent, Jason .
BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 (06) :1136-1140
[3]   Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma [J].
Chari, Ajai ;
Vogl, Dan T. ;
Gavriatopoulou, Maria ;
Nooka, Ajay K. ;
Yee, Andrew J. ;
Huff, Carol A. ;
Moreau, Philippe ;
Dingli, David ;
Cole, Craig ;
Lonial, Sagar ;
Dimopoulos, Meletios ;
Stewart, A. Keith ;
Richter, Joshua ;
Vij, Ravi ;
Tuchman, Sascha ;
Raab, Marc S. ;
Weisel, Katja C. ;
Delforge, Michel ;
Cornell, Robert F. ;
Kaminetzky, David ;
Hoffman, James E. ;
Costa, Luciano J. ;
Parker, Terri L. ;
Levy, Moshe ;
Schreder, Martin ;
Meuleman, Nathalie ;
Frenzel, Laurent ;
Mohty, Mohamad ;
Choquet, Sylvain ;
Schiller, Gary ;
Comenzo, Raymond L. ;
Engelhardt, Monika ;
Illmer, Thomas ;
Vlummens, Philip ;
Doyen, Chantal ;
Facon, Thierry ;
Karlin, Lionel ;
Perrot, Aurore ;
Podar, Klaus ;
Kauffman, Michael G. ;
Shacham, Sharon ;
Li, Lingling ;
Tang, Shijie ;
Picklesimer, Carla ;
Saint-Martin, Jean-Richard ;
Crochiere, Marsha ;
Chang, Hua ;
Parekh, Samir ;
Landesman, Yosef ;
Shah, Jatin .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (08) :727-738
[4]   Plasma Circulating Tumor HPV DNA for the Surveillance of Cancer Recurrence in HPV-Associated Oropharyngeal Cancer [J].
Chera, Bhishamjit S. ;
Kumar, Sunil ;
Shen, Colette ;
Amdur, Robert ;
Dagan, Roi ;
Green, Rebecca ;
Goldman, Emily ;
Weiss, Jared ;
Grilley-Olson, Juneko ;
Patel, Shetal ;
Zanation, Adam ;
Hackman, Trevor ;
Blumberg, Jeff ;
Patel, Samip ;
Thorp, Brian ;
Weissler, Mark ;
Yarbrough, Wendell ;
Sheets, Nathan ;
Mendenhall, William ;
Tan, Xianming M. ;
Gupta, Gaorav P. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (10) :1050-+
[5]   Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial [J].
Drayson, Mark T. ;
Bowcock, Stella ;
Planche, Tim ;
Iqbal, Gulnaz ;
Pratt, Guy ;
Yong, Kwee ;
Wood, Jill ;
Raynes, Kerry ;
Higgins, Helen ;
Dawkins, Bryony ;
Meads, David ;
Hulme, Claire T. ;
Monahan, Irene ;
Karunanithi, Kamaraj ;
Dignum, Helen ;
Belsham, Edward ;
Neilson, Jeff ;
Harrison, Beth ;
Lokare, Anand ;
Campbell, Gavin ;
Hamblin, Michael ;
Hawkey, Peter ;
Whittaker, Anna C. ;
Low, Eric ;
Dunn, Janet A. .
LANCET ONCOLOGY, 2019, 20 (12) :1760-1772
[6]   A single-center retrospective cohort analysis of venetoclax in relapsed/refractory multiple myeloma [J].
Kambhampati, Swetha ;
Galligan, Derek ;
Huang, Chiung-Yu ;
Wong, Sandy ;
Wolf, Jeffrey ;
Martin, Thomas ;
Shah, Nina .
LEUKEMIA & LYMPHOMA, 2020, 61 (05) :1211-1219
[7]  
Kumar S., 2019, HEMASPHERE, V3
[8]   Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma [J].
Kumar, Shaji ;
Kaufman, Jonathan L. ;
Gasparetto, Cristina ;
Mikhael, Joseph ;
Vij, Ravi ;
Pegourie, Brigitte ;
Benboubker, Lofti ;
Facon, Thierry ;
Amiot, Martine ;
Moreau, Philippe ;
Punnoose, Elizabeth A. ;
Alzate, Stefanie ;
Dunbar, Martin ;
Xu, Tu ;
Agarwal, Suresh K. ;
Enschede, Sari Heitner ;
Leverson, Joel D. ;
Ross, Jeremy A. ;
Maciag, Paulo C. ;
Verdugo, Maria ;
Touzeau, Cyrille .
BLOOD, 2017, 130 (22) :2401-2409
[9]   International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma [J].
Kumar, Shaji ;
Paiva, Bruno ;
Anderson, Kenneth C. ;
Durie, Brian ;
Landgren, Ola ;
Moreau, Philippe ;
Munshi, Nikhil ;
Lonial, Sagar ;
Blade, Joan ;
Mateos, Maria-Victoria ;
Dimopoulos, Meletios ;
Kastritis, Efstathios ;
Boccadoro, Mario ;
Orlowski, Robert ;
Goldschmidt, Hartmut ;
Spencer, Andrew ;
Hou, Jian ;
Chng, Wee Joo ;
Usmani, Saad Z. ;
Zamagni, Elena ;
Shimizu, Kazuyuki ;
Jagannath, Sundar ;
Johnsen, Hans E. ;
Terpos, Evangelos ;
Reiman, Anthony ;
Kyle, Robert A. ;
Sonneveld, Pieter ;
Richardson, Paul G. ;
McCarthy, Philip ;
Ludwig, Heinz ;
Chen, Wenming ;
Cavo, Michele ;
Harousseau, Jean-Luc ;
Lentzsch, Suzanne ;
Hillengass, Jens ;
Palumbo, Antonio ;
Orfao, Alberto ;
Rajkumar, S. Vincent ;
Miguel, Jesus San ;
Avet-Loiseau, Herve .
LANCET ONCOLOGY, 2016, 17 (08) :E328-E346
[10]   Updated Analysis of Bellini, a Phase 3 Study of Venetoclax or Placebo in Combination with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma [J].
Moreau, Philippe ;
Harrison, Simon ;
Cavo, Michele ;
De La Rubia, Javier ;
Popat, Rakesh ;
Gasparetto, Cristina ;
Hungria, Vania T. M. ;
Salwender, Hans ;
Suzuki, Kenshi ;
Kim, Inho ;
Gay, Francesca ;
Mikala, Gabor ;
Punnoose, Elizabeth A. ;
Hong, Wan-Jen ;
Sood, Anjla ;
Jalaluddin, Muhammad ;
Ross, Jeremy A. ;
Ward, James E. ;
Maciag, Paulo C. ;
Kumar, Shaji K. .
BLOOD, 2019, 134
12